Search research articles
Contact Us
Filters
Showing results (381-390 of 487) with videos related to
Page
of 49
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
December 12, 2022
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series
Kevin J Contrera, Maria K Gule-Monroe, Mimi I Hu, et al.
Experimental Hematology & Oncology
|
December 30, 2021
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
Kyaw Z Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Scientific Reports
|
May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
Shuyang Yao, Funda Meric-Bernstam, David Hong, et al.
JCO Precision Oncology
|
October 16, 2018
Clinical Use of Precision Oncology Decision Support
Amber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Clinical Breast Cancer
|
July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit
Debora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.
Oncotarget
|
May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms
Jennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
George D Demetri, Jason J Luke, Antoine Hollebecque, et al.
Oncology and Therapy
|
March 19, 2024
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer
Mary K Nesline, Vivek Subbiah, Rebecca A Previs, et al.
Oncology
|
November 2, 2016
Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit
Holly Kinahan, Abhishek Maiti, Kenneth Hess, et al.
Clinical Genitourinary Cancer
|
August 4, 2014
MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors
Denis L F Jardim, Débora de Melo Gagliato, Gerald Falchook, et al.
Page
of 49
Search research articles
Search
Showing results (381-390 of 487) with videos related to
Sort By:
Page
of 49
Thyroid : Official Journal of the American Thyroid Association
|
December 12, 2022
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series
Kevin J Contrera, Maria K Gule-Monroe, Mimi I Hu, et al.
Experimental Hematology & Oncology
|
December 30, 2021
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
Kyaw Z Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Scientific Reports
|
May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
Shuyang Yao, Funda Meric-Bernstam, David Hong, et al.
JCO Precision Oncology
|
October 16, 2018
Clinical Use of Precision Oncology Decision Support
Amber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Clinical Breast Cancer
|
July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit
Debora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.
Oncotarget
|
May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms
Jennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
George D Demetri, Jason J Luke, Antoine Hollebecque, et al.
Oncology and Therapy
|
March 19, 2024
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer
Mary K Nesline, Vivek Subbiah, Rebecca A Previs, et al.
Oncology
|
November 2, 2016
Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit
Holly Kinahan, Abhishek Maiti, Kenneth Hess, et al.
Clinical Genitourinary Cancer
|
August 4, 2014
MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors
Denis L F Jardim, Débora de Melo Gagliato, Gerald Falchook, et al.
Page
of 49